DENdritic Cell Immunotherapy for Mesothelioma
Clinical trial NCT03610360 · COMPLETED
Trial details
- NCT number
- NCT03610360
- Sponsor
- Amphera BV
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2022-06-30
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.